PTEN and prostate carcinoma: According to the ensemble of these observations, it was concluded that ERG activation, induced by the TMPRSS2-ERG rearrangement, has an important role in prostate cancer progression and cooperates with PTEN haploinsufficiency to promote prostate cancer progression [109].